BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10194126)

  • 1. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
    Uckun FM; Nachman JB; Sather HN; Sensel MG; Kraft P; Steinherz PG; Lange B; Hutchinson R; Reaman GH; Gaynon PS; Heerema NA
    Leuk Lymphoma; 1999 Mar; 33(1-2):101-6. PubMed ID: 10194126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
    Chen H; Liu KY; Xu LP; Chen YH; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ
    Leuk Res; 2017 Aug; 59():136-141. PubMed ID: 28654842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group.
    Uckun FM; Nachman JB; Sather HN; Sensel MG; Kraft P; Steinherz PG; Lange B; Hutchinson R; Reaman GH; Gaynon PS; Heerema NA
    Cancer; 1998 Nov; 83(9):2030-9. PubMed ID: 9806664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
    Faderl S; Kantarjian HM; Thomas DA; Cortes J; Giles F; Pierce S; Albitar M; Estrov Z
    Leuk Lymphoma; 2000 Jan; 36(3-4):263-73. PubMed ID: 10674898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute lymphoblastic leukemia with Philadelphia chromosome: eight case reports].
    Laatiri MA; Chehata S; Amouri A; Sendi HS; Saad A; Ennabli S
    Tunis Med; 2001 Jan; 79(1):38-41. PubMed ID: 11332342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
    Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
    Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Salami K; Alkayed K; Halalsheh H; Hussein AA; Riziq M; Madanat F
    Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):34-41. PubMed ID: 23664604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro drug resistance to imatinib and mutation of ABL gene in childhood Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.
    Kawaguchi H; Taketani T; Hongo T; Park MJ; Koh K; Ida K; Kobayashi M; Takita J; Taki T; Yoshino H; Bessho F; Hayashi Y
    Leuk Lymphoma; 2005 Feb; 46(2):273-6. PubMed ID: 15621812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
    Schultz KR; Pullen DJ; Sather HN; Shuster JJ; Devidas M; Borowitz MJ; Carroll AJ; Heerema NA; Rubnitz JE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Gaynon PS; Camitta BM
    Blood; 2007 Feb; 109(3):926-35. PubMed ID: 17003380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of adolescents and young adults with acute lymphoblastic leukemia.
    DeAngelo DJ
    Hematology Am Soc Hematol Educ Program; 2005; ():123-30. PubMed ID: 16304369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
    Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of imatinib for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in children].
    Guo Y; Liu TF; Ruan M; Yang WY; Chen XJ; Zhang L; Wang SC; Liu F; Zhang JY; Liu XM; Qi BQ; Zou Y; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):819-24. PubMed ID: 26287346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.
    Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E
    Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
    Heerema NA; Harbott J; Galimberti S; Camitta BM; Gaynon PS; Janka-Schaub G; Kamps W; Basso G; Pui CH; Schrappe M; Auclerc MF; Carroll AJ; Conter V; Harrison CJ; Pullen J; Raimondi SC; Richards S; Riehm H; Sather HN; Shuster JJ; Silverman LB; Valsecchi MG; Aricò M; ; ; ; ; ; ; ; ; ; ;
    Leukemia; 2004 Apr; 18(4):693-702. PubMed ID: 15044926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
    Motlló C; Ribera JM; Morgades M; Granada I; Montesinos P; Mercadal S; González-Campos J; Moreno MJ; Barba P; Cervera M; Barrios M; Novo A; Bernal T; Hernández-Rivas JM; Abella E; Amigo ML; Tormo M; Martino R; Lavilla E; Bergua J; Serrano A; García-Belmonte D; Guàrdia R; Grau J; Feliu E;
    Leuk Lymphoma; 2018 Jan; 59(1):146-154. PubMed ID: 28554259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Aricò M; Valsecchi MG; Camitta B; Schrappe M; Chessells J; Baruchel A; Gaynon P; Silverman L; Janka-Schaub G; Kamps W; Pui CH; Masera G
    N Engl J Med; 2000 Apr; 342(14):998-1006. PubMed ID: 10749961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson R; Nachman JB; Lange BJ; Steinherz PG; Bostrom B; Gaynon PS; Uckun FM
    Cancer; 2000 Apr; 88(8):1945-54. PubMed ID: 10760773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
    Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
    Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.